Thymostimulin therapy in melanoma patients: Correlation of immunologic effects with clinical course
- 1 September 1983
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 28 (3) , 311-324
- https://doi.org/10.1016/0090-1229(83)90098-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Enhancement of the immune system of chemotherapy-treated cancer patients by simultaneous treatment with thymic extract, TP-1Cancer Immunology, Immunotherapy, 1980
- Immunologic and Clinical Investigation on a Bovine Thymic Extract. Therapeutic Applications in Primary ImmunodeficienciesPediatric Research, 1979
- Relationship between T and B lymphocyte values and prognosis in malignant melanomaBritish Journal of Dermatology, 1978
- The biologic activity of MER-BCG in experimental systems and preliminary clinical studiesCancer Treatment Reviews, 1977
- SEVERE DISSEMINATED ADENOVIRUS INFECTION SUCCESSFULLY TREATED WITH A THYMIC HUMORAL FACTOR, THFActa Paediatrica, 1977
- Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factorInternational Journal of Cancer, 1975
- Thymosin Activity in Patients with Cellular ImmunodeficiencyNew England Journal of Medicine, 1975
- Thymus-Derived Rosette-Forming Cells in Various Human Disease States: Cancer, Lymphoma, Bacterial and Viral Infections, and Other DiseasesJournal of Clinical Investigation, 1973
- IMMUNOGLOBULIN SPOTS ON THE SURFACE OF RABBIT LYMPHOCYTESThe Journal of Experimental Medicine, 1970
- Enhancement of lung adenoma formation by neonatal thymectomy in mice treated with 7,12‐dimethylbenz(a)anthracene or urethanInternational Journal of Cancer, 1967